The Experts in Animal Health

printer friendly version

Brakke Consulting’s
Animal Health News & Notes for November 20, 2007
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon, DVM, MBA
earnings news
other news
ABS Global
Belcher Pharmaceuticals
Vetoquinol USA
2008 U.S. Animal Health Industry Overview
As we’ve done for a number of years, Brakke Consulting will be presenting our 2008 Animal Health Industry Overview at both the North American Veterinary Conference and the Western Veterinary Conference.
The Overview will contain industry highlights and the 2008 outlook, industry statistics in key product markets, recent financial/acquisition activity, observation of leading companies, veterinary practice trends update, summary data from Brakke multi-client studies, and more.  To register, go to and follow the link to register for the Overview of your choice.
> Virbac S.A. reported sales of EUR 110 million ($157 million) in the third quarter of 2007, an increase of 11% compared to the third quarter of 2006. The company said that all geographic zones grew significantly, apart from the Africa and the Pacific. (Animal Pharm)  
> Phibro Animal Health Corporation reported results for its fiscal year 2007.  Sales of the animal health and nutrition businesses rose by 13% to $360 million. Phibro attributed the growth to an increase in overall higher selling prices resulting from an increase in the cost of raw materials. (Animal Pharm)
2007 has been a year of dynamic change in the flea, tick and heartworm markets, with a number of new product introductions from both new and established players in the segment.
Brakke Consulting will soon be publishing our latest annual report on the US Flea Control and Heartworm Markets.  In addition to our annual survey of over 250 small animal veterinarians, this year’s report will include coverage of the many new products introduced this year, including Advantage Multi, ProMeris, Vectra 3D, and Comfortis.
The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $4,995 if ordered by WEDNESDAY, NOVEMBER 21, and $5,500 after that date. 
Please contact Dr. Lynn Fondon at (972) 243-4033 or to pre-order the report or for more information, or visit our website and download the order form at
> Schering-Plough Corporation announced that it has completed the acquisition of Organon BioSciences N.V.  The transaction will make Schering-Plough a global leader in Animal Health through the combination of Schering-Plough Animal Health and Intervet. Schering-Plough acquired Organon BioSciences from Akzo Nobel N.V. for approximately EUR 11 billion ($16 billion) in cash. (PR Newswire)
> GeoPharma, Inc. and Vetoquinol USA announced an agreement for the marketing and distribution of Vetprofen (carprofen) nationwide. The agreement executed with GeoPharma’s wholly-owned subsidiary Belcher Pharmaceuticals represents GeoPharma’s first generic drug offering. (PR Newswire)
> ABS Global announced it is now providing information from Merial’s IGENITY profile on all sires in its beef lineup. The IGENITY profile provides information about traits of economic importance, as well as a diagnostic test for identifying cattle persistently infected with bovine viral diarrhea (BVD-PI). (company press release)
>  UK – AVIAN INFLUENZA   Testing has confirmed an outbreak of highly pathogenic avian influenza in turkeys at a second site in the United Kingdom. The outbreak occurred at a farm deemed a “dangerous contact” premise, which was placed under restriction following the first outbreak last week. An almost 2-mile protection zone has been established around the second site, and the existing surveillance zone has been extended. (Meating Place)
All of us at Brakke Consulting want to wish each of our subscribers and clients a Happy Thanksgiving!
Ron Brakke
Ken Berkholtz
Ray Collier
Lynn Fondon
Jim Guenther
Atsuo Hata
Jay Lockhart
John Mannhaupt
Susan Mannhaupt
Christine Merle
Richard Miles
Jane Morgan
Kevin Scott
John Volk
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
2735 Villa Creek, Suite 140
Dallas, TX  75234    USA


en_USEnglish (United States)